Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phigenix
AddedFeb 16, 2024
UpdatedJun 18, 2026
Phigenix

Phigenix

Pre-Seed

Phigenix Pharmaceuticals: Pioneering Personalized Medicine with patented technology.

HQ
Atlanta, GA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Phigenix Pharmaceuticals, founded with a mission to revolutionize personalized medicine, focuses on developing advanced diagnostics and targeted therapies for cancer treatment. Leveraging a robust portfolio of over 100 patents and pending patents, the company aims to provide state-of-the-art technology that assists physicians in determining optimal treatment regimes for prostate and breast cancer patients. Phigenix's core vision is to lead the field of personalized healthcare by offering innovative solutions that enhance patient outcomes.

Notable figures affiliated with Phigenix include leading experts in oncology and biotechnology, although specific names are not provided. The company has attracted significant attention from investors due to its pioneering approach and strong intellectual property portfolio. Key achievements include the development of proprietary diagnostic tests that have the potential to transform cancer treatment protocols. Overall, Phigenix's impact lies in its commitment to advancing personalized medicine, thereby improving the precision and effectiveness of cancer therapies.

Phigenix - Similar Companies

NX Pharmagen logo

NX Pharmagen

nxpharmagen.com

PanGenX logo

PanGenX

Foundation Medicine logo

Foundation Medicine

Novagenic logo

Novagenic

novagenic.com

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

Phdx logo

Phdx

EcoGenome logo

EcoGenome

ecogenomellc.com

Precision Theranostics logo

Precision Theranostics

Phoenix Biotechnology logo

Phoenix Biotechnology

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

Genetron Health logo

Genetron Health

genetronhealth.com

Phoenix Life Sciences International logo

Phoenix Life Sciences International

phoenixlife.co

Personal Genome Diagnostics logo

Personal Genome Diagnostics

personalgenome.com

Phanes Therapeutics logo

Phanes Therapeutics

phanesthera.com

Affigen logo

Affigen

affigen.com

Phigenix - Quick Facts

Who are Phigenix's competitors?

Companies similar to Phigenix include NX Pharmagen, PanGenX, Foundation Medicine and Novagenic.

When was Phigenix founded?

Phigenix was founded in 2007.

Where is Phigenix's headquarters located?

Phigenix's headquarters is located in Atlanta, GA, US.

When was Phigenix's last funding round?

Phigenix's most recent funding round was for $842.4k (USD) in August 2015.

How much has Phigenix raised to-date?

As of Aug 19, 2015, Phigenix has raised a total of $4.6M (USD).

How many employees does Phigenix have?

Phigenix has 5 employees as of Feb 5, 2024.

Phigenix - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified